Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

Conditions: Chronic Lymphocytic Leukemia Interventions: Other: Observation Sponsors: Gruppo Italiano Malattie EMatologiche dell ' Adulto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials